Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,930,530)	$ (443,718)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	135,105	42,175
Stock-based compensation	445,869	54,635
Changes in assets and liabilities:
Accounts receivable	(133,458)	15,795
Inventories	(69,866)	105,114
Prepaid expenses and other assets	(76,896)	17,150
Accounts payable	71,327	27,722
Accrued expenses and other liabilities	1,407,079	4,547
Contract liability	22,779	(223,494)
Net cash used in operating activities	(1,128,591)	(359,629)
CASH FLOW FROM INVESTING ACTIVITIES:
Purchases of fixed assets	(82,990)	(2,284)
Acquisition of MicaSense	(12,990,121)
Platform development costs	(205,780)
Net cash used in investing activities	(13,278,891)	(2,284)
CASH FLOWS FROM FINANCING ACTIVITIES:
Sales of Common Stock, net of issuance cost	6,313,943
Sale of Common Stock from exercise of warrants	8,305,368
Exercise of stock options	41,380
Net cash provided by financing activities	14,660,691
Net (decrease) increase in cash	253,209	(361,913)
Cash at the beginning of the year	23,940,333	717,997
Cash at the end of the period	24,193,542	356,084
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest cash paid
Income taxes paid
Accrued dividends on Series D Preferred Stock		40,445
NONCASH INVESTING AND FINANCING ACTIVITIES:
Conversion of Series C Preferred Stock into Common Stock		189
Liability related to MicaSense Acquisition	6,578,775
Stock Consideration for Micasense Acquisition	$ 3,000,000